Riverside Company to exit Diatron

The Riverside Company has agreed to sell Diatron Group to STRATEC Biomedical AG of Germany. Financial terms weren’t announced. Budapest-based Diatron develops, makes and markets compact hematology analyzers for the human medical and veterinary markets. Lincoln International AG, Allen & Overy and E&Y advised Riverside on the transaction.

DealsNorth AmericaUSBriefs